Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04536870 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study

Study acronym: STAREE-HEART
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary endpoints: 2 to 1 Enrollment target: 364 to 369 · Study sites: 1 to 2 · Secondary endpoints: 1 to 2 · 2 morev3 Show 5 more changesShow less
    • Enrollment target: 364 to 369
    • Study sites: 1 to 2
    • Secondary endpoints: 1 to 2
    • Collaborators: 1 to 2
    • Study description shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  2. Primary and study completion dates: Dec 2022 to Dec 2026 Trial status: Recruiting to Active, Not Recruiting · Enrollment target: estimated 500 to confirmed 364 · Site details revisedv2 Show 3 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 500 to confirmed 364
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The STAREE-HEART sub-study will examine the effect of statin treatment over a 3-year period compared with placebo on markers of cardiac ageing (myocardial dysfunction). This will include determining global longitudinal strain with transthoracic echocardiography, atrial fibrillation with home measures twice daily for two weeks and changes in biomarkers.
Trial Details
NCT Number NCT04536870
Lead Sponsor Monash University
Collaborators: National Health and Medical Research Council, Australia, Curtin University
Conditions Heart Failure, Atrial Fibrillation, Healthy Ageing, Hypercholesterolemia, Myocardial Dysfunction
Enrollment 369 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov